The American pharmaceutical sector is experiencing a seismic change as artificial intelligence (AI) and predictive analytics reshape conventional methods of drug development and physician interaction. In oncology, where treatment is complicated and constantly changing, the capacity to predict prescribing behavior can transform patient care, lower costs, and drive innovation.